Universidad de Valencia, Facultad de Psicología, Departamento de Personalidad, Evaluación y Tratamiento Psicológico, Avda. Blasco Ibañez, 21, CP 46010, Valencia, Spain.
Ciber Fisiopatologia Obesidad y Nutrición (CB06/03), Instituto Salud Carlos III, Madrid, Spain.
BMC Psychol. 2023 Mar 30;11(1):88. doi: 10.1186/s40359-023-01138-x.
Eating disorders (EDs) are serious disorders that significantly affect not only the lives of patients, but also those of their family members who often experience high levels of burden, suffering and helplessness. If, in addition to ED, the patient has a personality disorder (PD), the psychological distress experienced by family members can be devastating. However, few treatments have been developed for family members of people with ED and PD. Family Connections (FC) is a programme that has been shown to be effective for family members of people with borderline personality disorder. The overall aims of this work are: (a) to adapt FC for application to family members of patients with BPD-PD (FC: ED-PD); (b) to analyse, in a randomised controlled clinical trial, the efficacy of this programme in a Spanish population, compared to a control condition consisting of treatment as usual optimised treatment (TAU-O); (c) to analyse the feasibility of the intervention protocol; (d) to analyse whether the changes that may occur in relatives are related to improvements in the family climate and/or improvements observed in patients; and (e) to analyse the perceptions and opinions of relatives and patients about the two intervention protocols.
The study uses a two-arm randomised controlled clinical trial with two experimental conditions: adaptation of FC programme (FC: ED-PD) or Treatment as usual optimised (TAU-O). Participants will be family members of patients who meet DSM-5 criteria for ED and PD or dysfunctional personality traits. Participants will be assessed before and after treatment and at one-year follow-up. The intention-to-treat principle will be used when analysing the data.
The results obtained are expected to confirm the effectiveness of the programme and its good acceptance by family members. Trial registration ClinicalTrials.gov Identifier: NCT05404035. Accepted: May 2022.
饮食失调(ED)是一种严重的疾病,不仅严重影响患者的生活,也严重影响其家属的生活,这些家属常常承受着巨大的负担、痛苦和无助感。如果患者除 ED 外还有人格障碍(PD),则其家属所经历的心理困扰可能是毁灭性的。然而,针对 ED 和 PD 患者家属的治疗方法却很少。“家庭联系”(FC)是一种已被证明对边缘型人格障碍患者家属有效的方案。这项工作的总体目标是:(a)改编 FC 方案,使之适用于患有 BPD-PD 的患者的家属(FC:ED-PD);(b)在西班牙人群中,通过随机对照临床试验分析该方案与作为对照的常规治疗优化治疗(TAU-O)相比的疗效;(c)分析干预方案的可行性;(d)分析亲属发生的变化是否与家庭氛围的改善以及/或患者观察到的改善有关;以及(e)分析亲属和患者对两种干预方案的看法和意见。
本研究采用了一项两臂随机对照临床试验,有两种实验组:FC 方案的改编(FC:ED-PD)或常规治疗优化(TAU-O)。参与者将是符合 DSM-5 标准的 ED 和 PD 或功能失调性人格特质患者的家属。参与者将在治疗前、治疗后和一年随访时进行评估。数据分析将采用意向治疗原则。
预计研究结果将证实该方案的有效性及其得到家属的良好接受程度。试验注册临床Trials.gov 标识符:NCT05404035。接受日期:2022 年 5 月。